Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FDJ56
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,114
Award facts
- Contract value 100% obligated
- $43,113.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $43,113.50 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-unit quantity) on May 20, 2025. This firm fixed-price delivery order, with an ultimate completion date of May 21, 2025, is being fulfilled from the vendor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a woman-owned small business.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. Xtandi, an oncology treatment, exemplifies the types of specialized prescription medications the contractor regularly supplies to Department of Defense healthcare sites. DMS Pharmaceutical Group's established role as a critical pharmaceutical supplier in the federal supply chain is reflected in its consistent track record of securing delivery orders for branded and generic prescription drugs, biologics, and medical consumables across the military healthcare system.
Quick answers
Who was awarded contract SPE2DB25FDJ56?
SPE2DB25FDJ56 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 20, 2025.
How much is contract SPE2DB25FDJ56 worth?
The government has obligated $43,114 on SPE2DB25FDJ56.
Is contract SPE2DB25FDJ56 an order under another contract?
Yes. SPE2DB25FDJ56 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDJ56 competed?
The extent of competition for SPE2DB25FDJ56 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award